talkEHR Signings Hit a New Milestone
"We're pleased that so many healthcare providers are signing up to explore talkEHR and excited about the planned launch of the next version of talkEHR in June 2018," said
talkEHR — MTBC's next generation SaaS EHR solution — is designed to utilize natural language processing and artificial intelligence to automate key components of patient charting and reduce manual tasks and errors. talkEHR is offered completely free of cost to all
Healthcare providers interested in learning more can visit www.talkEHR.com.
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."
For additional information, please visit our website at www.mtbc.com.
This press release contains various forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "intends," "expects," "plans," "goals," "projects," "anticipates," "believes," "estimates," "predicts," "potential," or "continue" or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions.
These forward-looking statements
are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry's) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company's ability to: manage growth; effectively and timely identify, close and ramp-up new business; effectively and timely identify, close and integrate acquisition targets; effectively migrate and keep newly acquired customers; retain existing and new customers; increase operational
efficiency and reduce operating costs; predict and properly adjust to changes in reimbursement and other industry rules and trends; comply with contractual obligations and controlling laws; comply with covenants contained in our credit agreement; retain the services of key personnel; and other important risks and uncertainties referenced and discussed under the heading titled "Risk Factors" in the Company's filings with the
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
Rachel GrossingerMarketing Manager Medical Transcription Billing, Corp.email@example.com 732-873-5133 Investor Contact: Bill KornChief Financial Officer Medical Transcription Billing, Corp.firstname.lastname@example.org 732-873-5133
News Provided by Acquire Media